Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antidepressive agents AND citalopram AND depressive disorder:

Search results

Items: 1 to 20 of 1647

1.

Efficacy and Safety for the Newer Antidepressants in Adults [Internet].

Sæterdal I, Pike E, Ringerike T, Gjertsen MK.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2007 Jun.

2.

Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression.

Burstein O, Franko M, Gale E, Handelsman A, Barak S, Motsan S, Shamir A, Toledano R, Simhon O, Hirshler Y, Chen G, Doron R.

PLoS One. 2017 Nov 15;12(11):e0188043. doi: 10.1371/journal.pone.0188043. eCollection 2017.

3.

Efficacy of escitalopram monotherapy in the treatment of major depressive disorder: A pooled analysis of 4 Chinese clinical trials.

Li G, Shen Y, Luo J, Li H.

Medicine (Baltimore). 2017 Sep;96(39):e8142. doi: 10.1097/MD.0000000000008142.

4.

Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.

Steiner AJ, Recacho J, Vanle B, Dang J, Wright SM, Miller JS, Kauzor K, Reid M, Bashmi LE, Mirocha J, Danovitch I, IsHak WW.

J Clin Psychiatry. 2017 Jul;78(7):897-903. doi: 10.4088/JCP.16m11335.

PMID:
28858443
5.

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.

Westin AA, Brekke M, Molden E, Skogvoll E, Spigset O.

PLoS One. 2017 Jul 14;12(7):e0181082. doi: 10.1371/journal.pone.0181082. eCollection 2017. Erratum in: PLoS One. 2018 Jan 16;13(1):e0191508.

6.

Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.

Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, Veronezi BP, Nogueira BS, Aparicio LVM, Razza LB, Chamorro R, Tort LC, Fraguas R, Lotufo PA, Gattaz WF, Fregni F, Benseñor IM; ELECT-TDCS Investigators.

N Engl J Med. 2017 Jun 29;376(26):2523-2533. doi: 10.1056/NEJMoa1612999.

7.

Serotonergic 5HTTLPR/rs25531 s-allele homozygosity associates with violent suicides in male citalopram users.

Rahikainen AL, Majaharju S, Haukka J, Palo JU, Sajantila A.

Am J Med Genet B Neuropsychiatr Genet. 2017 Oct;174(7):691-700. doi: 10.1002/ajmg.b.32553. Epub 2017 Jun 13.

PMID:
28608626
8.

Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the simultaneous determination of 12 new antidepressants and 2 antipsychotics in whole blood by gas chromatography-mass spectrometry.

Chen X, Zheng S, Le J, Qian Z, Zhang R, Hong Z, Chai Y.

J Pharm Biomed Anal. 2017 Aug 5;142:19-27. doi: 10.1016/j.jpba.2017.04.032. Epub 2017 Apr 29.

PMID:
28494335
9.

Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom.

Young AH, Evitt L, Brignone M, Diamand F, Atsou K, Campbell R, Cure S, Danchenko N.

J Affect Disord. 2017 Aug 15;218:291-298. doi: 10.1016/j.jad.2017.04.019. Epub 2017 Apr 17.

PMID:
28478358
10.

The genome-wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant response.

Powell TR, Murphy T, de Jong S, Lee SH, Tansey KE, Hodgson K, Uher R, Price J, Thuret S, Breen G.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):427-434. doi: 10.1002/ajmg.b.32532. Epub 2017 Apr 10.

11.

Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.

Dunlop BW, Kelley ME, Aponte-Rivera V, Mletzko-Crowe T, Kinkead B, Ritchie JC, Nemeroff CB, Craighead WE, Mayberg HS; PReDICT Team.

Am J Psychiatry. 2017 Jun 1;174(6):546-556. doi: 10.1176/appi.ajp.2016.16050517. Epub 2017 Mar 24.

PMID:
28335624
12.

Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS.

Am J Psychiatry. 2017 Jun 1;174(6):533-545. doi: 10.1176/appi.ajp.2016.16050518. Epub 2017 Mar 24. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

PMID:
28335622
13.

Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study.

Chiarotti F, Viglione A, Giuliani A, Branchi I.

Transl Psychiatry. 2017 Mar 21;7(3):e1066. doi: 10.1038/tp.2017.35.

14.

Gene expression and proliferation biomarkers for antidepressant treatment resistance.

Breitfeld J, Scholl C, Steffens M, Laje G, Stingl JC.

Transl Psychiatry. 2017 Mar 14;7(3):e1061. doi: 10.1038/tp.2017.16.

15.

Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.

Chekroud AM, Gueorguieva R, Krumholz HM, Trivedi MH, Krystal JH, McCarthy G.

JAMA Psychiatry. 2017 Apr 1;74(4):370-378. doi: 10.1001/jamapsychiatry.2017.0025.

PMID:
28241180
16.

Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.

Zhou C, Zhong J, Zou B, Fang L, Chen J, Deng X, Zhang L, Zhao X, Qu Z, Lei Y, Lei T.

PLoS One. 2017 Feb 27;12(2):e0172270. doi: 10.1371/journal.pone.0172270. eCollection 2017.

17.

Transcriptomic profiling of human hippocampal progenitor cells treated with antidepressants and its application in drug repositioning.

Powell TR, Murphy T, Lee SH, Price J, Thuret S, Breen G.

J Psychopharmacol. 2017 Mar;31(3):338-345. doi: 10.1177/0269881117691467. Epub 2017 Feb 16.

18.

Differentiating residual symptoms of depression from adverse events among patients initiating treatment with an antidepressant.

Freeman MP, Fisher L, Clain A, Rabbitt R, Pooley J, Baer L, Fava M.

Ann Clin Psychiatry. 2017 Feb;29(1):28-34.

PMID:
28207913
19.

In patients suffering from major depressive disorders, quantitative EEG showed favorable changes in left and right prefrontal cortex.

Haghighi M, Ludyga S, Rahimi B, Jahangard L, Ahmadpanah M, Torabian S, Esnaashari F, Nazaribadie M, Bajoghli H, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S.

Psychiatry Res. 2017 May;251:137-141. doi: 10.1016/j.psychres.2017.02.012. Epub 2017 Feb 6.

PMID:
28199912
20.

Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.

Carney CE, Edinger JD, Kuchibhatla M, Lachowski AM, Bogouslavsky O, Krystal AD, Shapiro CM.

Sleep. 2017 Apr 1;40(4). doi: 10.1093/sleep/zsx019.

PMID:
28199710

Supplemental Content

Loading ...
Support Center